Summary by Futu AI
Recursion Pharmaceuticals, Inc. Director Blake Borgeson is set to sell 20,054 Class A shares of the company, with an aggregate market value of $241,805.99, on 03/05/2024. These shares were originally acquired on 09/01/2016 as founder's shares and were part of Borgeson's compensation from the issuer. This upcoming transaction follows a series of sales over the past three months, where a total of 103,110 shares were sold for gross proceeds of $1,136,736.04.